go back

PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY (PNPO)

PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY (PNPO)
PNPO; SEIZURES, PYRIDOXINE-RESISTANT, PLP-SENSITIVE
610090
OMIM = Online Mendelian Inheritance of Men
79096
pyridoxamine 5-prime-phosphate oxidase
1.4.3.5
17q21.32
G40.8
rare
autosomal recessive
mutation in the PNPO gene
Laboratory findings5-Hydroxyindolacetic acid (5-HIAA) dec (cerebrospinal fluid)
D-Glucose normal/dec (plasma)
Pyridoxal 5-prime-phosphate (PLP) dec (cerebrospinal fluid)
Vanillic acid inc (urine)
   Homovanillic acid (HVA) dec (cerebrospinal fluid)
   L-Threonine normal/inc (plasma)
   L-Threonine normal/inc (cerebrospinal fluid)
   Vanillactic acid n/i (urine)
    Arginine dec (cerebrospinal fluid)
    Glycine inc (plasma)
    Glycine inc (cerebrospinal fluid)
    L-Histidine inc (cerebrospinal fluid)
    L-Lactic acid normal/inc (blood)
    Phosphatase, alkaline normal/inc (serum)
    Taurine inc (cerebrospinal fluid)
Symptomshypoglycemia
   developmental delay
   dystonia
   EEG abnormalities [-]
   epilepsy
   hypotonia
   low APGAR Score
   microcephaly (<2 SD for age)
   prematurity, premature delivery
   seizures
    anemia
    cirrhosis or fibrosis of liver
    encephalopathy
    eye movements, abnormal
    failure to thrive
    feeding difficulties, poor feeding
    hypertonia, spasticity
    metabolic acidosis
    MRI, brain, abnormalities [-]
    myoclonus
    onset, neonatal
    retinopathy
    vomiting